Upadacitinib for difficult‐to‐treat paediatric Crohn's disease
Abstract Paediatric‐onset inflammatory bowel disease (IBD) has an enormous impact on healthcare systems as it translates to a lifetime of healthcare. Since the approval of anti‐tumour necrosis factor‐alpha agents, it has become evident that in the long journey of paediatric IBD, there is an absolute need for more treatment options.
N. Nedelkopoulou+3 more
wiley +1 more source
A case of Corynebacterium propinquum microbial keratitis after amniotic membrane transplantation. [PDF]
Yukari Y+5 more
europepmc +1 more source
Abstract Objectives The use of biologic therapy is increasing in pediatric patients with inflammatory bowel disease (IBD). However, efficacy may be compromised by increased drug clearance and anti‐drug antibodies (ADAs). Historically, concomitant immunomodulator therapy (CIT) has been used to prevent ADA formation. Pediatric studies evaluating CIT have
Kenneth Grant+3 more
wiley +1 more source
Repurposing drugs to advance the treatment of Buruli ulcer. [PDF]
Singh S+3 more
europepmc +1 more source
ABSTRACT Objectives Despite biological treatments reducing the burden of pediatric inflammatory bowel disease, many patients still require surgery. Data on pediatric patient characteristics and surgical incidence are limited, often based on adult studies.
Hugo Gagnon+6 more
wiley +1 more source
Case Report: Spesolimab for pyoderma gangrenosum in an undifferentiated oligoarthritis patient receiving anti-IL-17 therapy. [PDF]
Xin W, Gu L, Du F, Li T, Ye S.
europepmc +1 more source
Exploring the potential protective and anti-inflammatory effects of the crude ethanolic extract of <i>Annona squamosa Linn</i> fruit against Ethanol-mediated gastric erosion. [PDF]
Al-Zubaidi HJ+4 more
europepmc +1 more source
Tuberculosis of the tongue in a patient with rheumatoid arthritis treated with methotrexate and adalimumab. [PDF]
Assante LR+5 more
core
COLLAB: A Global Survey of Clinical and Laboratory Assessment in Alopecia Areata by Hair Specialists
ABSTRACT Background Alopecia areata (AA) is a common non‐scarring alopecia. Data continue to emerge on associations with autoimmune and other conditions. Janus kinase inhibitors (JAKi) are increasingly used to treat AA. Objectives The aim was to assess variation in laboratory testing in patients with AA among hair experts internationally and to compare
Cathal O'Connor+39 more
wiley +1 more source